Chris MacDonald

Chris MacDonald

Chris MacDonald is an MBA (finance) graduate with extensive experience covering small-, mid- and large-cap companies in the U.S. and Canadian markets. Chris is interesting in uncovering long-term and deep-value opportunities for investors based on principles from the Graham-Buffett school of thought, and looks forward to bringing investors a unique fundamental-based perspective on opportunities available in today’s challenging investing environment.

His experience as a financial analyst in the past, coupled with his fervor for finding undervalued growth opportunities, contribute to his conservative, long-term investing perspective.

Recent Articles

3 Undervalued Cryptos With Insane Upside Potential

These three undervalued cryptos are worth considering in this beaten-down market, as long as the market rebounds as many hope.

3 Best Fertilizer Stocks to Buy Now

The search for the best fertilizer stocks is on, as this sector sees significant volatility following various geopolitical events of late. Here are three that have outperformed the sector and look like they'll continue to do so through the agriculture cycle.

SIGA Stock Gains Another 11% on Monkeypox Virus Concerns

SIGA stock is continuing to rally on Tuesday as a ruling by the WHO has renewed investor interest in so-called monkeypox stocks.

Why Is InflaRx (IFRX) Stock Up 40% Today?

Today's news that InflaRx plans to apply for FDA emergency-use authorization for its Covid-19 treatment has IFRX stock surging.

Pagaya Technologies (PGY) Stock Soars Another 100%

Today, investors in Pagaya Technologies and PGY stock are seeing another triple-digit percentage move higher on little news.